Cargando…

Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios

Introduction Attitudes toward medical cannabis are shaped by a number of factors, such as religion, previous use, and political affiliation. Individuals with less supportive beliefs toward cannabis, in general, may be more open to its therapeutic applications in a humanized patient scenario (PS). Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Clobes, Thomas A, Arellano, Mya, Gagnon, Matin, Klaiman, Colby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507077/
https://www.ncbi.nlm.nih.gov/pubmed/36168378
http://dx.doi.org/10.7759/cureus.28354
_version_ 1784796841532981248
author Clobes, Thomas A
Arellano, Mya
Gagnon, Matin
Klaiman, Colby
author_facet Clobes, Thomas A
Arellano, Mya
Gagnon, Matin
Klaiman, Colby
author_sort Clobes, Thomas A
collection PubMed
description Introduction Attitudes toward medical cannabis are shaped by a number of factors, such as religion, previous use, and political affiliation. Individuals with less supportive beliefs toward cannabis, in general, may be more open to its therapeutic applications in a humanized patient scenario (PS). Methods A modified medical cannabis attitude scale was used to measure participants' attitudes toward medical cannabis. Two humanized patient scenarios were presented to the participants, and their level of agreement with the patient having access to medical cannabis was measured. After the scales were standardized, a Wilcoxon signed-rank test (WSR) was utilized to determine whether a difference between medical cannabis attitudes and approval of medical cannabis use in the humanized PS exists. Results A total of 645 participants completed the full survey and were included in the data analysis. Most participants were supportive of the patients in the humanized scenarios having access to medical cannabis; 76.1% and 75.7% of respondents, in each of the scenarios, selected the highest level of approval. There was a significantly higher approval for medical cannabis with the PS than attitudes toward medical cannabis in general (Z=-17.415, p<0.0005). Conclusion Individuals were more supportive of patient access to medical cannabis when exposed to humanized PS than their general attitudes toward medical cannabis indicated. Applying the results of this current research, a viable plan to reduce the stigma surrounding cannabis is to use patient testimonials in public-facing advocacy efforts regarding medical cannabis.
format Online
Article
Text
id pubmed-9507077
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-95070772022-09-26 Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios Clobes, Thomas A Arellano, Mya Gagnon, Matin Klaiman, Colby Cureus Public Health Introduction Attitudes toward medical cannabis are shaped by a number of factors, such as religion, previous use, and political affiliation. Individuals with less supportive beliefs toward cannabis, in general, may be more open to its therapeutic applications in a humanized patient scenario (PS). Methods A modified medical cannabis attitude scale was used to measure participants' attitudes toward medical cannabis. Two humanized patient scenarios were presented to the participants, and their level of agreement with the patient having access to medical cannabis was measured. After the scales were standardized, a Wilcoxon signed-rank test (WSR) was utilized to determine whether a difference between medical cannabis attitudes and approval of medical cannabis use in the humanized PS exists. Results A total of 645 participants completed the full survey and were included in the data analysis. Most participants were supportive of the patients in the humanized scenarios having access to medical cannabis; 76.1% and 75.7% of respondents, in each of the scenarios, selected the highest level of approval. There was a significantly higher approval for medical cannabis with the PS than attitudes toward medical cannabis in general (Z=-17.415, p<0.0005). Conclusion Individuals were more supportive of patient access to medical cannabis when exposed to humanized PS than their general attitudes toward medical cannabis indicated. Applying the results of this current research, a viable plan to reduce the stigma surrounding cannabis is to use patient testimonials in public-facing advocacy efforts regarding medical cannabis. Cureus 2022-08-24 /pmc/articles/PMC9507077/ /pubmed/36168378 http://dx.doi.org/10.7759/cureus.28354 Text en Copyright © 2022, Clobes et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Public Health
Clobes, Thomas A
Arellano, Mya
Gagnon, Matin
Klaiman, Colby
Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios
title Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios
title_full Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios
title_fullStr Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios
title_full_unstemmed Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios
title_short Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios
title_sort differences in attitudes toward medical cannabis with humanized patient scenarios
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507077/
https://www.ncbi.nlm.nih.gov/pubmed/36168378
http://dx.doi.org/10.7759/cureus.28354
work_keys_str_mv AT clobesthomasa differencesinattitudestowardmedicalcannabiswithhumanizedpatientscenarios
AT arellanomya differencesinattitudestowardmedicalcannabiswithhumanizedpatientscenarios
AT gagnonmatin differencesinattitudestowardmedicalcannabiswithhumanizedpatientscenarios
AT klaimancolby differencesinattitudestowardmedicalcannabiswithhumanizedpatientscenarios